Insulet
PODD
731 hedge funds and large institutions have $10.9B invested in Insulet in 2026 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 329 increasing their positions, 254 reducing their positions, and 138 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 329 | Existing positions reduced: 254
4.69% more ownership
Funds ownership: 98.88% → 103.56% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less call options, than puts
Call options by funds: $23.8M | Put options by funds: $25.8M
7% less funds holding
Funds holding: 788 → 731 (-57)
25% less capital invested
Capital invested by funds: $14.6B → $10.9B (-$3.67B)
34% less first-time investments, than exits
New positions opened: 91 | Existing positions closed: 138
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$190M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$143M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$107M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$103M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$99.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$502M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$252M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$245M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$127M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$72.1M |
PODD Hedge Fund Activity: Q2 2026 in Review
731 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2026, worth a combined $10.9B — down 25% from $14.6B a quarter earlier.
Sellers outnumbered buyers: 138 funds closed out of PODD and 91 opened new positions — a net loss of 47 holders — while 254 trimmed existing stakes and 329 added.
The largest buyer was Two Sigma Investments, adding an estimated $190M. The largest seller was Fidelity Investments, cutting an estimated $502M.
- 731 institutional investors held Insulet (PODD) as of Q2 2026, down from 788 in Q1 2026.
- Funds reported $10.9B of Insulet stock for Q2 2026, down 25% quarter-over-quarter.
- 91 funds opened new Insulet positions in Q2 2026 and 138 closed out, a net change of -47 holders.
- The largest Insulet buyer in Q2 2026 was Two Sigma Investments, an estimated $190M added.
- The largest Insulet seller in Q2 2026 was Fidelity Investments, an estimated $502M sold.
Based on aggregated 13F filings for Q2 2026.